<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/monitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/monitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2017-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2017-03-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/monitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp/"},"url":"https://clinicaltree.github.io/posts/monitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp/"}</script><title>Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Monitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1490979600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2017 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Georg Bier MD</a> </em>, <em> <a href="">Mustafa Kurucay MD</a> </em>, <em> <a href="">Jörg Henes MD</a> </em>, <em> <a href="">Theodoros Xenitidis MD</a> </em>, <em> <a href="">Heike Preibsch MD</a> </em>, <em> <a href="">Konstantin Nikolaou MD</a> </em>, <em> <a href="">Marius Horger MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2209 words"> <em>12 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To evaluate the role of perfusion CT for monitoring inflammatory activity in patients with aortitis and chronic periaortitis undergoing immunosuppressive therapy.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Seventeen symptomatic patients (median age 68.5 years) who underwent perfusion-based computed tomography (CT) monitoring after diagnostic contrast-enhanced CT were retrospectively included in this study. Blood flow (BF), blood volume (BV), volume transfer constant (k-trans), time to peak, and mean transit time were determined by setting circular regions of interest in prominently thickened parts of the vessel wall or perfused surrounding tissue at sites where the perfusion CT color maps showed a maximum BF value. Differences in CT perfusion and, morphological parameters, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were tested for significance during therapy.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In all patients BF and BV dropped at second perfusion CT ( <em>P</em> &lt; 0.05). In aortitis patients, CRP dropped from 3.86 ± 5.31 mg/dL to 0.9 ± 1.37 mg/dL and in periaortitis patients from 1.78 ± 2.25 mg/dL to 0.79 ± 1.55 mg/dL, whereas ESR dropped from 45.71 ± 37.59 seconds to 8.57 ± 3.1 seconds and 36.78 ± 34.67 seconds to 17.22 ± 21.82 seconds in aortitis and in periaortitis, respectively.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The course of perfusion CT parameters in aortitis and chronic periaortitis undergoing immunosuppressive therapy dropped at different extent after therapy.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Inflammatory disorders of the large vessel walls or such arising around large vessels are rare and generally difficult to diagnose because of discrete, unspecific symptoms and poor or partially missing serologic alterations. Aortitis and periaortitis (A/PA) are all-encompassing terms ascribed to these disorders. Due to the fact that large-vessel vasculitis and periaortitic conditions are commonly autoimmune-mediated and may be associated with other, potentially severe systemic diseases, imaging plays a major role in their diagnosis. Moreover, histological proof is mostly impracticable and risky. To limit these mostly incurable pathological conditions, immunosuppressive therapy is necessary and, once a diagnosis has been verified, generally prompted.</p><p>Morphological changes such as regression of pathological vessel wall thickening or perivascular tissue formation are expected during immunosuppression, but their magnitude and temporal course are quite variable and depend on the histological substrate (eg, inflammation vs. fibrosis) . Some of the retroperitoneal fibrosis persists even after successful systemic therapy . Using serological parameters like erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and even leukocyte count has been proposed for monitoring these entities, but they can fail in up to 22% of cases, in particular in patients with PA. Moreover, these follow-up markers rapidly turn normal after onset of some novel therapeutic agents . Therefore, functional imaging techniques have advanced to the methods of choice in A/PA diagnosis, assessment of disease activity, and even therapy monitoring. Among them, magnetic resonance imaging (MRI) is capable of demonstrating vessel wall edema by increased T2-signal in the vessel wall as already reported in patients with Takayasu’s arteritis or giant cell aortitis . Complementary, contrast enhancement in postcontrast T1w MRI sequences is considered more sensitive and a surrogate for inflammation-related angiogenesis . Another very frequently applied imaging technique in this clinical setting is 18F-fludeoxyglucose positron emission tomography (FDG-PET), reported to be a highly sensitive imaging tool that increases overall diagnostic accuracy and has a beneficial impact on medical management . However, due to its high sensitivity, FDG–PET-positive findings rapidly normalize during immunosuppression (hours—few days) so that the course of the underlying autoimmune process cannot be reliably assessed anymore.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-data"><span class="mr-2">Clinical Data</span><a href="#clinical-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Characteristics</p><p>Parameter_n_ = 17 % Age (64.4 ± 8.16 years) Gender Male 9 52.9 Female 8 47.1 Aortitis 5 29.4 Periaortitis 12 70.6 IAA 3 17.6 Retroperitoneal fibrosis 9 60 New diagnoses 12 70.6 Relapsing disease 5 29.4 Symptoms at baseline Abdominal pain 5 29.4 Urinary obstruction 5 29.4 Weight loss 4 23.5 Night sweats 4 23.5 Exhaustion 1 5.9 Back pain 1 5.9 Fever 1 5.9 Vertigo 1 5.9</p><p>IAA, inflammatory aortic aneurysm.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="laboratory-data"><span class="mr-2">Laboratory Data</span><a href="#laboratory-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-imaging"><span class="mr-2">CT Imaging</span><a href="#ct-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="perfusion-ct-imaging"><span class="mr-2">Perfusion CT Imaging</span><a href="#perfusion-ct-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="morphologic-ct-image-analysis"><span class="mr-2">Morphologic CT Image Analysis</span><a href="#morphologic-ct-image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="functional-perfusion-ct-image-analysis"><span class="mr-2">Functional Perfusion CT Image Analysis</span><a href="#functional-perfusion-ct-image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistics"><span class="mr-2">Statistics</span><a href="#statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="clinical-data-1"><span class="mr-2">Clinical Data</span><a href="#clinical-data-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="laboratory-data-1"><span class="mr-2">Laboratory Data</span><a href="#laboratory-data-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>CRP and ESR Values (Median and Range) and Significance Level ( <em>P</em> ) at Baseline and the Second CT for Aortitis and Periaortitis</p><p>Disorder CRP Baseline (mg/dL) CRP Follow-Up (mg/dL)<em>P</em> ESR Baseline (mm/h) ESR Follow-Up (mm/h)<em>P</em> Aortitis 1.8(0.04–15.25) 0.4(0.01–4.08) 0.039 37(6–112) 8(5–12) 0.016 Periaortitis 0.8(0.05–6.87) 0.12(0.03–4.8) 0.15 22(7–99) 12(7–75) 0.09 Total 1.57(0.04–15.25) 0.22(0.01–2.08) 0.044 23.5(6–112) 9.5(5–75) 0.006</p><p>CRP, C-reactive protein; CT, computed tomography; ESR, erythrocyte sedimentation rate.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="morphologic-image-data"><span class="mr-2">Morphologic Image Data</span><a href="#morphologic-image-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MonitoringDiseaseActivityinPatientswithAortitisandChronicPeriaortitisUndergoingImmunosuppressiveTherapybyPerfusionCT/0_1s20S1076633216303932.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MonitoringDiseaseActivityinPatientswithAortitisandChronicPeriaortitisUndergoingImmunosuppressiveTherapybyPerfusionCT/0_1s20S1076633216303932.jpg" alt="Figure 1, A 72-year-old male patient with periaortitis of the abdominal aorta. After admission CT (a) with thickening of the aortic wall and reactive perivascular tissue consolidation, a methotrexate therapy was initiated. The second CT (b) reveals a significant reduction of the vessel wall diameter. The color-coded VPCT parameter maps before (c,e) and after (d,f) therapy additionally show the reduction of the blood flow (c,d) and blood volume (e,f) , and therefore microperfusion inside the vessel wall. CT, computed tomography; VPCT, volume-perfusion CT." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="functional-image-data"><span class="mr-2">Functional Image Data</span><a href="#functional-image-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Pairwise Correlation of VPCT, and Morphological and Serological Parameters</p><p>Parameter Mean Difference ± SD CRP ESR Diameter_r__P__r__P__r__P_ Blood flow (mL/100 mL/min) −24.85±17.62 0.04 0.9 0.02 0.95 0.15 0.63 Blood volume (mL/100 mL/min) −4.34±3.23 −0.21 0.51 −0.09 0.76 0.19 0.55 Time to peak (second) 4.35 ± 4.52 −0.46 0.13 −0.22 0.5 0.05 0.87 Mean time of transit (second) −5.33±4.45 −0.06 0.86 0.3 0.34 −0.57 0.052 k-trans (mL/100 mL/min) 10.37 ± 8.79 0.62 0.03 0.81 0.002 −0.33 0.29</p><p>CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; VPCT, volume-perfusion CT.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>VPCT Parameters (Mean ± SD) at Baseline and Follow-Up for Aortitis Patients Plus <em>P</em> Values</p><p>VPCT Parameter Baseline Follow-Up_P_ Blood flow 52.94 ± 26.61 23.45 ± 18.98 0.020 Blood volume 11.21 ± 5.07 6.34 ± 4.83 0.008 Time to peak 12.15 ± 2.62 13.58 ± 2.23 0.939 Mean transit time 5.73 ± 2.99 4.38 ± 1.94 0.061 k-trans 13.41 ± 9.47 11.59 ± 7.73 0.561</p><p>VPCT, volume-perfusion CT.</p><p>VPCT values are given in mL/100 mL/min.</p><p>Table 5</p><p>VPCT Parameters (Mean ± SD) at Baseline and Follow-Up for Periaortitis Patients Plus <em>P</em> Values</p><p>VPCT Parameter Baseline Follow-Up_P_ Blood flow 39.11 ± 15.54 19.71 ± 11.07 0.007 Blood volume 8.32 ± 2.53 4.83 ± 2.86 0.009 Time to peak 14.05 ± 3.48 16.2 ± 6.48 0.418 Mean transit time 8.06 ± 4.07 8.82 ± 8.57 0.560 k-trans 17.13 ± 10.56 12.59 ± 10.81 0.156</p><p>VPCT, volume-perfusion CT.</p><p>VPCT values are given in mL/100 mL/min.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MonitoringDiseaseActivityinPatientswithAortitisandChronicPeriaortitisUndergoingImmunosuppressiveTherapybyPerfusionCT/1_1s20S1076633216303932.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MonitoringDiseaseActivityinPatientswithAortitisandChronicPeriaortitisUndergoingImmunosuppressiveTherapybyPerfusionCT/1_1s20S1076633216303932.jpg" alt="Figure 2, Box plot diagrams of blood flow (a,b) and blood volume (c,d) before and after therapy subdivided by the presence or absence of symptoms at second perfusion CT. CT, computed tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Restrepo C.S., Ocazionez D., Suri R., et. al.: Aortitis: imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics 2011; 31: pp. 435-451.</p><li><p>2. Meller J., Grabbe E., Becker W., et. al.: Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003; 13: pp. 400-405.</p><li><p>3. Spira D., Kotter I., Ernemann U., et. al.: Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach. AJR Am J Roentgenol 2010; 194: pp. 848-856.</p><li><p>4. Seror O., Fain O., Dordea M., et. al.: Aortitis with antiphospholipid antibodies: CT and MR findings. Eur Radiol 1998; 8: pp. 1373-1375.</p><li><p>5. Vaglio A., Greco P., Versari A., et. al.: Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent “scar”? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005; 23: pp. 231-234.</p><li><p>6. Loricera J., Blanco R., Castaneda S., et. al.: Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol 2014; 32: pp. S79-S89.</p><li><p>7. Spira D., Xenitidis T., Henes J., et. al.: MRI parametric monitoring of biological therapies in primary large vessel vasculitides—a pilot study. Br J Radiol 2015; 89: pp. 20150892.</p><li><p>8. Lavado-Perez C., Martinez-Rodriguez I., Martinez-Amador N., et. al.: (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica. Rev Esp Med Nucl Imagen Mol 2015; 34: pp. 275-281.</p><li><p>9. Heston T.F., Szabo Z.: Giant cell arteritis on 18F-FDG PET/CT. Clin Physiol Funct Imaging 2009; 29: pp. 382-384.</p><li><p>10. Hayashida T., Sueyoshi E., Sakamoto I., et. al.: PET features of aortic diseases. AJR Am J Roentgenol 2010; 195: pp. 229-233.</p><li><p>11. Bier G., Henes J., Eulenbruch C., et. al.: Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT morphological, clinical and serological data. Br J Radiol 2015; 88: pp. 20150526.</p><li><p>12. Grozinger G., Balletshofer B., Horger M.: Volume perfusion CT image of an inflammatory infrarenal aortic aneurysm. Rheumatology 2013; 52: pp. 459.</p><li><p>13. Litmanovich D.E., Yildirim A., Bankier A.A.: Insights into imaging of aortitis. Insights Imaging 2012; 3: pp. 545-560.</p><li><p>14. Palmisano A., Vaglio A.: Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009; 23: pp. 339-353.</p><li><p>15. Arnaud L., Haroche J., Malek Z., et. al.: Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?. Arthritis Rheum 2009; 60: pp. 1193-1200.</p><li><p>16. Webb M., Chambers A., Al-Nahhas A., et. al.: The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004; 31: pp. 627-634.</p><li><p>17. Tezuka D., Haraguchi G., Ishihara T., et. al.: Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012; 5: pp. 422-429.</p><li><p>18. Feinstein R.S., Gatewood O.M., Goldman S.M., et. al.: Computerized tomography in the diagnosis of retroperitoneal fibrosis. J Urol 1981; 126: pp. 255-259.</p><li><p>19. Weyand C.M., Goronzy J.J.: Pathogenic principles in giant cell arteritis. Int J Cardiol 2000; 75: pp. S9-S15. discussion S7–S9</p><li><p>20. Liozon E., Boutros-Toni F., Ly K., et. al.: Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumatol 2003; 30: pp. 1272-1276.</p><li><p>21. Cavalcanti Filho J.L., de Souza Leao Lima R., de Souza Machado Neto L., et. al.: PET/CT and vascular disease: current concepts. Eur J Radiol 2011; 80: pp. 60-67.</p><li><p>22. Slobodin G., Nakhleh A., Rimar D., et. al.: Increased aortic wall thickness for the diagnosis of aortitis: a computed tomography-based study. Int J Rheum Dis 2015; 19: pp. 82-86.</p><li><p>23. Iino M., Kuribayashi S., Imakita S., et. al.: Sensitivity and specificity of CT in the diagnosis of inflammatory abdominal aortic aneurysms. J Comput Assist Tomogr 2002; 26: pp. 1006-1012.</p><li><p>24. Salvarani C., Pipitone N., Versari A., et. al.: Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005; 53: pp. 298-303.</p><li><p>25. Bruls S., Courtois A., Nusgens B., et. al.: 18F-FDG PET/CT in the management of aortitis. Clin Nucl Med 2016; 41: pp. 28-33.</p><li><p>26. Loricera J., Blanco R., Hernandez J.L., et. al.: Use of positron emission tomography (PET) for the diagnosis of large-vessel vasculitis. Rev Esp Med Nucl Imagen Mol 2015; 34: pp. 372-377.</p><li><p>27. Kok J., Lin M., Patapanian H., et. al.: [18F]FDG PET/CT in the diagnosis of large vessel vasculitis. Intern Med J 2009; 39: pp. 267-269.</p><li><p>28. Kuehl H., Eggebrecht H., Boes T., et. al.: Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CTimaging and serological markers of inflammation. Heart 2008; 94: pp. 1472-1477.</p><li><p>29. Blockmans D.: The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 2003; 21: pp. S15-S22.</p><li><p>30. Truijers M., Kurvers H.A., Bredie S.J., et. al.: In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther 2008; 15: pp. 462-467.</p><li><p>31. Caiafa R.O., Vinuesa A.S., Izquierdo R.S., et. al.: Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics 2013; 33: pp. 535-552.</p><li><p>32. Wen D., Du X., Ma C.S.: Takayasu arteritis: diagnosis, treatment and prognosis. Int Rev Immunol 2012; 31: pp. 462-473.</p><li><p>33. Kaufmann S., Horger T., Oelker A., et. al.: Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique. Eur J Radiol 2015; 84: pp. 1029-1035.</p><li><p>34. Yun M., Yeh D., Araujo L.I., et. al.: F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001; 26: pp. 314-319.</p><li><p>35. Papathanasiou N.D., Du Y., Menezes L.J., et. al.: 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol 2012; 85: pp. e188-e194.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-24/'>Volume 24</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Monitoring%20Disease%20Activity%20in%20Patients%20with%20Aortitis%20and%20Chronic%20Periaortitis%20Undergoing%20Immunosuppressive%20Therapy%20by%20Perfusion%20CT%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmonitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Monitoring%20Disease%20Activity%20in%20Patients%20with%20Aortitis%20and%20Chronic%20Periaortitis%20Undergoing%20Immunosuppressive%20Therapy%20by%20Perfusion%20CT%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmonitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmonitoring-disease-activity-in-patients-with-aortitis-and-chronic-periaortitis-undergoing-immunosupp%2F&text=Monitoring%20Disease%20Activity%20in%20Patients%20with%20Aortitis%20and%20Chronic%20Periaortitis%20Undergoing%20Immunosuppressive%20Therapy%20by%20Perfusion%20CT%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/association-between-imaging-characteristics-and-different-molecular-subtypes-of-breast-cancer/"><div class="card-body"> <em class="small" data-ts="1490979600" data-df="ll" > Mar 31, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Association Between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer</h3><div class="text-muted small"><p> Rationale and Objective Breast cancer can be divided into four major molecular subtypes based on the expression of hormone receptor (estrogen receptor and progesterone receptor), human epidermal g...</p></div></div></a></div><div class="card"> <a href="/posts/clinical-application-of-dual-energy-spectral-computed-tomography-in-detecting-cholesterol-gallstones/"><div class="card-body"> <em class="small" data-ts="1490979600" data-df="ll" > Mar 31, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Clinical Application of Dual-Energy Spectral Computed Tomography in Detecting Cholesterol Gallstones From Surrounding Bile</h3><div class="text-muted small"><p> Rationale and Objective This study aimed to investigate the clinical value of spectral computed tomography (CT) in the detection of cholesterol gallstones from surrounding bile. Materials and Met...</p></div></div></a></div><div class="card"> <a href="/posts/comparison-and-optimization-of-3-0-t-breast-images-quality-of-diffusion-weighted-imaging-with-multip/"><div class="card-body"> <em class="small" data-ts="1490979600" data-df="ll" > Mar 31, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparison and Optimization of 3.0 T Breast Images Quality of Diffusion-Weighted Imaging with Multiple B-Values</h3><div class="text-muted small"><p> Rationale and Objectives Breast 3.0 T magnetic resonance diffusion-weighted imaging (MR-DWI) of benign and malignant lesions were obtained to measure and calculate the signal-to-noise ratio (SNR),...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/missteps-in-estimates-of-cancer-overdiagnosis/" class="btn btn-outline-primary" prompt="Older"><p>Missteps in Estimates of Cancer Overdiagnosis</p></a> <a href="/posts/peripheral-non-atherosclerotic-arterial-disorders/" class="btn btn-outline-primary" prompt="Newer"><p>Peripheral Non-atherosclerotic Arterial Disorders</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
